Annual Short Term Debt
$5.95 M
+$85.00 K+1.45%
December 31, 2023
Summary
- As of February 7, 2025, PSTX annual short term debt is $5.95 million, with the most recent change of +$85.00 thousand (+1.45%) on December 31, 2023.
- During the last 3 years, PSTX annual short term debt has risen by +$1.14 million (+23.77%).
Performance
PSTX Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Short Term Debt
$6.08 M
+$46.00 K+0.76%
September 30, 2024
Summary
- As of February 7, 2025, PSTX quarterly short term debt is $6.08 million, with the most recent change of +$46.00 thousand (+0.76%) on September 30, 2024.
- Over the past year, PSTX quarterly short term debt has increased by +$46.00 thousand (+0.76%).
Performance
PSTX Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
PSTX Short Term Debt Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +1.4% | +0.8% |
3 y3 years | +23.8% | +12.0% |
5 y5 years | - | - |
PSTX Short Term Debt Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -6.1% | -1.4% | -17.6% | -4.4% |
5 y | 5-year | -6.1% | -49.6% | -44.5% | -50.7% |
alltime | all time | -6.1% | -81.3% | -44.5% | -50.7% |
Poseida Therapeutics Short Term Debt History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $6.08 M(+0.8%) |
Jun 2024 | - | $6.04 M(+0.7%) |
Mar 2024 | - | $6.00 M(+0.7%) |
Dec 2023 | $5.95 M(+1.4%) | $5.95 M(+0.8%) |
Sep 2023 | - | $5.91 M(+0.7%) |
Jun 2023 | - | $5.86 M(+0.7%) |
Mar 2023 | - | $5.82 M(-0.8%) |
Dec 2022 | $5.87 M | $5.87 M(-12.9%) |
Sep 2022 | - | $6.74 M(+0.8%) |
Jun 2022 | - | $6.69 M(-9.5%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | $7.39 M(+16.6%) |
Dec 2021 | $6.34 M(+31.8%) | $6.34 M(+16.7%) |
Sep 2021 | - | $5.43 M(-3.7%) |
Jun 2021 | - | $5.64 M(-36.2%) |
Mar 2021 | - | $8.85 M(+84.0%) |
Dec 2020 | $4.81 M(+60.3%) | $4.81 M(+14.5%) |
Sep 2020 | - | $4.20 M(+0.5%) |
Jun 2020 | - | $4.18 M(-61.9%) |
Mar 2020 | - | $10.96 M(+265.5%) |
Dec 2019 | $3.00 M(+170.0%) | $3.00 M |
Dec 2017 | $1.11 M | - |
FAQ
- What is Poseida Therapeutics annual short term debt?
- What is the all time high annual short term debt for Poseida Therapeutics?
- What is Poseida Therapeutics annual short term debt year-on-year change?
- What is Poseida Therapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for Poseida Therapeutics?
- What is Poseida Therapeutics quarterly short term debt year-on-year change?
What is Poseida Therapeutics annual short term debt?
The current annual short term debt of PSTX is $5.95 M
What is the all time high annual short term debt for Poseida Therapeutics?
Poseida Therapeutics all-time high annual short term debt is $6.34 M
What is Poseida Therapeutics annual short term debt year-on-year change?
Over the past year, PSTX annual short term debt has changed by +$85.00 K (+1.45%)
What is Poseida Therapeutics quarterly short term debt?
The current quarterly short term debt of PSTX is $6.08 M
What is the all time high quarterly short term debt for Poseida Therapeutics?
Poseida Therapeutics all-time high quarterly short term debt is $10.96 M
What is Poseida Therapeutics quarterly short term debt year-on-year change?
Over the past year, PSTX quarterly short term debt has changed by +$46.00 K (+0.76%)